About this Event
Turning advanced science into a successful clinical programme requires more than innovation alone. The decisions made early—from CMC strategy and manufacturing to regulatory planning and investment readiness—can shape development timelines and influence long-term success.
Hosted by Thermo Fisher Scientific in association with the BioIndustry Association (BIA), Biotech Horizons - London 2026 brings together biotech founders, industry leaders, investors, and subject matter specialists to share practical strategies for preparing innovative therapies for the clinic.
What you'll gain
- Practical guidance to building an effective early-stage CMC strategy
- Specialist advice on preparing for IND and clinical readiness
- Lessons on avoiding common manufacturing and regulatory challenges
- Perspectives from investors on what strengthens development programmes
- Real-world experiences from biotech leaders who have navigated the journey to the clinic
- Opportunities to connect with peers across the biotech ecosystem
Date: 21 October 2026
Location: London Victoria House, 37-63 Southampton Row, London WC1B 4DR
Breakfast & Lunch Included
Event venue & nearby stays
Victoria House, 37-63 Southampton Row, London, United Kingdom